Infinity Pharmaceuticals | 10-Q: Q1 2023 Earnings Report
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
07:59
The first stock of the large medical model takes big action, leading the 300 billion medical AI track.
Iflytek Co.,ltd.-3.95%
07:58
Tan Yiming, an Analyst at Minsheng Securities, stated that based on historical experience, there is a high probability that the central bank will reduce the reserve requirement ratio once from December of the previous year to before the Spring Festival of the current year. This would help lower funding costs and relieve funding stratification, as well as contribute to a decrease in deposit certificate interest rates.
07:55
Morgan Stanley's Xing Ziqiang: The market can focus on the "New Three Major Projects".
MS+0.93%